Comments
Loading...
Citius Oncology (CTOR) Forecast
NewsEarningsCitius Oncology (CTOR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Citius Oncology Stock Price, Quotes and Forecasts | NASDAQ:CTOR | Benzinga
Explore Citius Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CTOR.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Citius Oncology (CTOR) stock?
You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.
Who are Citius Oncology (CTOR) competitors?
Other companies in Citius Oncology’s space includes: Serina Therapeutics (AMEX:SER), Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR) and CytomX Therapeutics (NASDAQ:CTMX).
What is the forecast, or price target, for Citius Oncology (CTOR) stock?
Citius Oncology has a consensus price target of $4.50.
What is the current price for Citius Oncology (CTOR)?
The stock price for Citius Oncology (NASDAQ: CTOR) is $0.7562 last updated March 25, 2025 at 1:15 PM EDT.
Does Citius Oncology (CTOR) pay a dividend?
There are no upcoming dividends for Citius Oncology.
When is Citius Oncology (NASDAQ:CTOR) reporting earnings?
Citius Oncology’s Q2 earnings are confirmed for Wednesday, May 21, 2025.
Is Citius Oncology (CTOR) going to split?
There is no upcoming split for Citius Oncology.
What sector and industry does Citius Oncology (CTOR) operate in?
Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.